Ralf Rosskamp
2019
In 2019, Ralf Rosskamp earned a total compensation of $2.2M as Chief Medical Officer at Dicerna Pharmaceuticals, a 111% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $229,424 |
|---|---|
| Option Awards | $1,465,200 |
| Salary | $458,848 |
| Other | $18,858 |
| Total | $2,172,330 |
Rosskamp received $1.5M in option awards, accounting for 67% of the total pay in 2019.
Rosskamp also received $229.4K in non-equity incentive plan, $458.8K in salary and $18.9K in other compensation.
Rankings
In 2019, Ralf Rosskamp's compensation ranked 5,502nd out of 13,971 executives tracked by ExecPay. In other words, Rosskamp earned more than 60.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,502 out of 13,971 | 61st |
Division Manufacturing | 2,055 out of 5,698 | 64th |
Major group Chemicals And Allied Products | 730 out of 2,197 | 67th |
Industry group Drugs | 614 out of 1,883 | 67th |
Industry Pharmaceutical Preparations | 452 out of 1,395 | 68th |
Source: SEC filing on April 22, 2020.
Rosskamp's colleagues
We found four more compensation records of executives who worked with Ralf Rosskamp at Dicerna Pharmaceuticals in 2019.